Laurus Labs shares tumble 4% despite 886% surge in Q2 PAT. Should you buy the dip?

Laurus Labs shares fell despite Q2FY26 PAT surging 886% to Rs 195 crore, revenue rising 35%, and EBITDA more than doubling, with margins expanding to 24.4%.